Search
for
Sort by
Research 271–300 of 319
- Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Probiotics in Dermatology: An Evidence-based Approach
- Phytochemicals and Nano-Phytopharmaceuticals Use in Skin, Urogenital and Locomotor Disorders: Are We There?
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Beyond the Surface: Understanding Demodex and Its Link to Blepharitis and Facial Dermatoses
- Skin manifestations associated with systemic diseases – Part I
- Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study
- Laser therapy in superficial morphea lesions – indications, limitations and therapeutic alternatives
- Medical aesthetics – Current trends and a review of its applications
- Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications
- Malassezia infection: is there any chance or necessity in refractory acne?
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
- Cosmetic adverse effects of antiseizure medications; A systematic review
- Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Off-label uses of retinoids in dermatology
- Cutaneous manifestation of polycystic ovary syndrome
- Malassezia Folliculitis versus Truncal Acne Vulgaris (Clinical and Histopathological Study)
- Exploring Pediatric Dermatology in Skin of Color: Focus on Dermoscopy
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- Diabetes mellitus and necrotizing fasciitis – a deadly combination; case report
- When bugs and drugs conspire: driving acneiform skin toxicity
- Azelaic acid stimulates catalase activation and promotes hair growth through upregulation of Gli1 and Gli2 mRNA and Shh protein.